
Heli
Harvala
professori, biolääketieteen laitos
MD, PhD, EUPHEM Alumni, FRCPath
Ota yhteyttä
Julkaisut
Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016-2020. (2022)
Emerging Infectious Diseases
Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization (2022)
Transfusion
Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial (2022)
Intensive Care Medicine
Evaluating the risk of transfusion and transplant-transmitted monkeypox infections (2022)
Transfusion Medicine
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response (2022)
Microbiology spectrum
Lessons learnt from syphilis-infected blood donors: a timely reminder of missed opportunities (2022)
Sexually Transmitted Infections
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern (2022)
Communications medicine
Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure (2021)
Journal of Clinical Virology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006-2017. (2021)
Emerging Infectious Diseases
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial (2021)
JAMA: Journal of the American Medical Association